Visterra visterrainc.com


Public lists: BIO 2016 (619)

Visterra, formerly Parasol Therapeutics, is a biotechnology company that uses its Hierotope Platform to identify unique disease targets and design effective therapeutics. The company's technology is powered by computational tools and techniques, called Atomic Interaction Network (AIN) analysis, which uniquely identifies an area, or epitope, on the target site that is fundamental to its structure and function. This ideal epitope, or hierotope, becomes the target against which the company designs ...Show all

Visterra, formerly Parasol Therapeutics, is a biotechnology company that uses its Hierotope Platform to identify unique disease targets and design effective therapeutics. The company's technology is powered by computational tools and techniques, call...Show all

Company (Alive / Active)

Phone: 617-498-1070

Fax:

One Kendall Square
Suite B3301
Cambridge, 02139
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Visterra $78.3M Mar 30, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Visterra Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 11 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Synthetic oligosaccharides for moraxella vaccine Feb 03, 2014 Sep 20, 2016 Patent
Antibody molecules to dengue virus and uses thereof Oct 23, 2015 Jun 14, 2016 Patent
Antibody molecules to dengue virus and uses thereof Jan 20, 2015 Dec 15, 2015 Patent
Ha binding agents Oct 16, 2014 Aug 04, 2015 Patent
Ha binding agents Oct 10, 2013 Nov 04, 2014 Patent
See all 7 patents